Cyclosporin
Sponsors
National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Stanford University, Karolinska University Hospital, St. Jude Children's Research Hospital
Conditions
Cardiac SurgeryDiabetes Mellitus, Type 2Diabetic NephropathyDry Eye Disease (DED)Dry Eye SyndromesGlomerulosclerosis, FocalHemophagocytic LymphohistiocytosisHyperkalaemia
Phase 1
Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation
CompletedNCT00705120
Start: 1995-11-30End: 2007-10-31Updated: 2008-06-25
Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects
CompletedNCT04788641
Start: 2021-03-30End: 2021-09-16Updated: 2024-04-05
Phase 2
Phase 3
Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)
CompletedNCT00135811
Start: 2004-11-30End: 2009-10-31Target: 207Updated: 2012-05-22
Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004
CompletedNCT00426101
Start: 2004-01-31End: 2017-12-31Updated: 2018-07-05
Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis
NCT03180723
Start: 2017-07-01End: 2019-12-31Target: 30Updated: 2017-06-16
Phase 4
Unknown Phase
Effect of Ciclosporin Eyedrops on Sjögren Syndrome
CompletedNCT04597762
Start: 2020-08-31End: 2021-03-31Updated: 2021-04-08
Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery
CompletedNCT05691764
Start: 2020-09-01End: 2022-09-01Updated: 2023-01-20
A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study
CompletedNCT07234318
Start: 2026-01-20End: 2026-06-01Updated: 2026-06-22